Functional characterization of two naturally occurring mutations (Val514Ala and Ala575Val) in follicle-stimulating hormone receptor

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 4, 2015, Pages E638-E645

  Desai, Swapna S ^a   Achrekar, Swati K ^a   Sahasrabuddhe, Krupa A ^a   Meharji, Parvin K ^a   Desai, Sadhana K ^b   Mangoli, Vijay S ^b   Mahale, Smita D ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN REPRODUCTIVE HEALTH   (India)

^b Fertility Clinic   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CHORIONIC GONADOTROPIN; CYCLIC AMP; FOLLITROPIN; FOLLITROPIN RECEPTOR; MUTANT PROTEIN; VALINE;

ADULT; ANIMAL CELL; ARTICLE; BIOACCUMULATION; CELL SURFACE; CHO CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; FERTILIZATION IN VITRO; FUNCTIONAL ASSESSMENT; GENE CONSTRUCT; HORMONE BINDING; HORMONE RECEPTOR INTERACTION; HUMAN; IN VITRO STUDY; INTERNALIZATION; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; ADOLESCENT; AMENORRHEA; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL; CASE REPORT; CRICETULUS; FEMALE INFERTILITY; GENETIC TRANSFECTION; GENETICS; HAMSTER; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; OVARY HYPERSTIMULATION;

CRICETULUS GRISEUS;

ADOLESCENT; ADULT; ALANINE; AMENORRHEA; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; BASE SEQUENCE; CHO CELLS; CRICETINAE; CRICETULUS; FEMALE; HUMANS; INFERTILITY, FEMALE; MUTATION, MISSENSE; OVARIAN HYPERSTIMULATION SYNDROME; RECEPTORS, FSH; TRANSFECTION; VALINE;

EID: 84927594205     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-3662     Document Type: Article

References (35)

1. Simoni M, Gromoll J, Nieschlag E. The follicle stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev. 1997;18:739-773.
2. Sanford JC, Batten BE. Endocytosis of follicle-stimulating hormone by ovarian granulosa cells: analysis of hormone processing and receptor dynamics. J Cell Physiol. 1989;138:154-164.
3. Richards JS, Midgley AR Jr. Protein hormone action: a key to understanding ovarian follicular and luteal cell development. Biol Reprod. 1976;14:82-94.
4. Dierich A, Sairam R, Monaco L, et al. Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc Natl Acad Sci USA. 1998;95:13612-13617.
5. Peltoketo H, Strauss L, Karjalainen R, et al. Female mice expressing constitutively active mutants of FSH receptor present with a phenotype of premature follicle depletion and estrogen excess. Endocrinology. 2010;15:1872-1883.
6. Aittomäki K, Dieguez Lucena J, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell. 1995;82:959-968.
7. Siegel ET, Kim HG, Nishimoto HK, Layman LC. The molecular basis of impaired follicle-stimulating hormone action: evidence from human mutations and mouse models. Reprod Sci. 2013;20:211-233.
8. Ulloa-Aguirre A, Zariñán T, Dias JA, Conn PM. Mutations in G protein-coupled receptors that impact receptor trafficking and reproductive function. Mol Cell Endocrinol. 2014;382:411-423.
9. Huhtaniemi IT, Themmen AP. Mutations in human gonadotropin and gonadotropin-receptor genes. Endocrine. 2005;26:207-217.
10. Huhtaniemi I, Alevizaki M. Mutations along the hypothalamic-pituitarygonadal axis affecting male reproduction. Reprod Biomed Online. 2007;15:622-632.
11. Gromoll J, Simoni M, Nieschlag E. An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. J Clin Endocrinol Metab 1996;81:1367-1370.
12. Casas-González P, Scaglia HE, Pérez-Solís MA, et al. Normal testicular function without detectable follicle-stimulating hormone. A novel mutation in the follicle-stimulating hormone receptor gene leading to apparent constitutive activity and impaired agonist-induced desensitization and internalization. Mol Cell Endocrinol. 2012;364:71-82.
13. Desai SS, Roy BS, Mahale SD. Mutations and polymorphisms in FSH receptor: functional implications in human reproduction. Reproduction. 2013;146:R235-R248.
14. Kaiser UB. The pathogenesis of the ovarian hyperstimulation syndrome. N Engl J Med. 2003;349:729-732.
15. Achrekar S, Modi D, Meherji P, Patel ZM, Mahale SD. Follicle stimulating hormone receptor gene variants in women with primary and secondary amenorrhea. J Assist Reprod Genet. 2010;27:317-326.
16. Desai SS, Achrekar SK, Pathak BR, et al. Follicle-stimulating hormone receptor polymorphism (G-29A) is associated with altered level of receptor expression in Granulosa cells. J Clin Endocrinol Metab. 2011;96:2805-2812.
17. Dias JA, Mahale SD, Nechamen CA, Davydenko O, Thomas RM, Ulloa-Aguirre A. Emerging roles for the FSH receptor adapter protein APPL1 and 114 overlap of a putative 14-3-3 α interaction domain with a canonical G-protein interaction site. Mol Cell Endocrinol. 2010;329:17-25.
18. Fraker PJ, Speck JC Jr. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1, 3, 4, 6-tetrachloro-3a, 6a-diphrenylglycoluril. Biochem Biophys Res Commun. 1978;80:849-857.
19. Dupakuntla M, Pathak B, Roy BS, Mahale SD. Extracellular loop 2 in the FSH receptor is crucial for ligand mediated receptor activation. Mol Cell Endocrinol. 2012;362:60-68.
20. Beau I, Touraine P, Meduri G, et al. A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. J Clin Invest. 1998;102:1352-1359.
21. Laven JS, Mulders AG, Suryandari DA, et al. Follicle-stimulating hormone receptor polymorphisms in women with normogonadotropic anovulatory infertility. Fertil Steril. 2003;80:986-992.
22. Daelemans C, Smits G, de Maertelaer V, et al. Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism. J Clin Endocrinol Metab. 2004;89:6310-6315.
23. Achrekar SK, Modi DN, Desai SK, Mangoli VS, Mangoli RV, Mahale SD. Follicle-stimulating hormone receptor polymorphism (Thr307Ala) is associated with variable ovarian response and ovarian hyperstimulation syndrome in Indian women. Fertil Steril. 2009;91:432-439.
24. Yan Y, Gong Z, Zhang L, et al. Association of follicle-stimulating hormone receptor polymorphisms with ovarian response in Chinese women: a prospective clinical study. PLoS One. 2013;8:e78138.
25. Smits G, Olatunbosun O, Delbaere A, Pierson R, Vassart G, Costagliola S. Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. NEngl J Med. 2003;349:760-766.
26. Vasseur C, Rodien P, Beau I, et al. A chorionic gonadotropin-sensitive mutation in the follicle-stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome. N Engl J Med. 2003;349:753-759.
27. Rizk DE, Castella A, Shaheen H, Deb P. Factor VII deficiency detected in pregnancy: a case report. Am J Perinatol. 1999;16:223-226.
28. Wang TH, Horng SG, Chang CL, et al. Human chorionic gonadotropininduced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor. J Clin Endocrinol Metab. 2002;87:3300-3308.
29. Uchida S, Uchida H, Maruyama T, et al. Molecular analysis of a mutated FSH receptor detected in a patient with spontaneous ovarian hyperstimulation syndrome. PLoS One. 2013;8:e75478.
30. Meduri G, Touraine P, Beau I, et al. Delayed puberty and primary amenorrhea associated with a novel mutation of the human folliclestimulating hormone receptor: clinical, histological, and molecular studies. J Clin Endocrinol Metab. 2003;88:3491-3498.
31. Janovick JA, Maya-Núñez G, Ulloa-Aguirre A, et al. Increased plasma membrane expression of human follicle-stimulating hormone receptor by a small molecule thienopyr (im) idine. Mol Cell Endocrinol. 2008;298:84-88.
32. Timossi C, Ortiz-Elizondo C, Pineda DB, Dias JA, Conn PM, Ulloa-Aguirre A. Functional significance of the BBXXB motif reversed present in the cytoplasmic domains of thehumanfollicle-stimulating hormone receptor. Mol Cell Endocrinol. 2004;223:17-26.
33. Kuechler A, Hauffa BP, Köninger A, et al. An unbalanced translocation unmasks a recessive mutation in the follicle-stimulating hormone receptor (FSHR) gene and causes FSH resistance. Eur J Hum Genet. 2010;18:656-661.
34. Yano K, Saji M, Hidaka A, et al. A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty. J Clin Endocrinol Metab. 1995;80:1162-1168.
35. Gozu HI, Bircan R, Krohn K, et al. Similar prevalence of somatic TSH receptor and Gsα mutations in toxic thyroid nodules in geographical regions with different iodine supply in Turkey. Eur J Endocrinol. 2006;155:535-545.